Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Best MK-677 Dosage Sleep Quality 2026: Protocol Comparison

5–10mg 60 min pre-bed 8–12% vs baseline 5–8 minutes Minimal. Occasional mild hunger upon waking Subtherapeutic for most adults; may benefit younger individuals with intact GH pulsatility 10–15mg 60–90 min pre-bed 15–22% vs baseline 10–15 minutes Mild transient

This comparison does not assign a generated winner or score.

  • 5–10mg
  • 60 min pre-bed
  • 8–12% vs baseline
  • 5–8 minutes
  • Minimal. Occasional mild hunger upon waking
  • Subtherapeutic for most adults; may benefit younger individuals with intact GH pulsatility
  • 10–15mg
  • 60–90 min pre-bed
  • 15–22% vs baseline
  • 10–15 minutes
  • Mild transient water retention (1–2 lbs); rare next-day grogginess
  • Optimal starting range for sleep improvement. Titrate within this window based on response
  • 20–25mg
  • 20–27% vs baseline
  • 12–18 minutes
  • Moderate water retention (2–4 lbs); increased fasting glucose 5–10 mg/dL; mild morning lethargy
  • Upper therapeutic range. Reserve for older adults or those with blunted GH response
  • 30mg+
  • Any timing
  • 18–25% vs baseline
  • Significant water retention (4–7 lbs); HPA axis activation; sleep fragmentation 4–6 AM; next-day fatigue
  • Exceeds sleep benefit threshold. Side effects outweigh marginal architectural gains
More references

Related material